PDX PHARMACEUTICALS
Pdx Pharmaceuticals is a Pharmaceutical company located in Portland.
PDX PHARMACEUTICALS
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2010-01-01
Address:
Portland, Oregon, United States
Country:
United States
Website Url:
http://www.pdxpharm.com
Total Employee:
11+
Status:
Active
Total Funding:
1.55 M USD
Technology used in webpage:
Viewport Meta Google Font API Apple Mobile Web Clips Icon WordPress WordPress 5.9 WPForms
Similar Organizations
Aclairo Pharmaceutical Development Group
Aclairo Pharmaceutical Development Group is a health care company located in Vienna.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.
Scilex Pharmaceuticals
Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products.
Teva Active Pharmaceutical Ingredients
Teva Active Pharmaceutical Ingredients is a Pharmaceuticals company located in Petah Tikva.
Current Employees Featured
Founder
Investors List
Kuni Foundation
Kuni Foundation investment in Series A - Pdx Pharmaceuticals
Official Site Inspections
http://www.pdxpharm.com Semrush global rank: 4.6 M Semrush visits lastest month: 2.21 K
- Host name: cloudproxy10165.sucuri.net
- IP address: 192.124.249.165
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Pdx Pharmaceuticals"
PDX Pharmaceuticals - LinkedIn
Join us in San Francisco, January 13โ15, 2025, with virtual sessions on January 16โ17 on the partneringONE platform, to showcase your organization and connect with strategic partners.See details»
Pdx Pharmaceuticals - Crunchbase Company Profile & Funding
Pdx Pharmaceuticals is a biopharmaceutical company. They provide common biological pathways to achieve synergistic clinical benefit. Their therapeutic candidates bridge the innate and โฆSee details»
PDX Pharmaceuticals - Overview, News & Similar companies
Who is PDX Pharmaceuticals. PDX Pharmaceuticals focuses on developing functionalized nanomaterials into drugs. We aspire to substantially improve health care using our nanotec โฆSee details»
PDX Pharmaceuticals Company Profile | Management and
Www.pdxpharm.com PDX Pharmaceuticals Profile and History PDX Pharmaceuticals, also known as Raksa Therapeutics, is a biopharmaceutical company focused on advancing cancer โฆSee details»
PDX Pharmaceuticals 2025 Company Profile: Valuation, Funding ...
PDX Pharmaceuticals General Information Description. Developer of functionalized nanomaterials designed to improve health care using nanotechnology. The company's platform is a hybrid of โฆSee details»
PDX Pharmaceuticals - Craft
PDX Pharmaceuticals has 5 employees at their 1 location and $1.55 m in total funding,. See insights on PDX Pharmaceuticals including office locations, competitors, revenue, financials, โฆSee details»
PDX Pharmaceuticals, Inc., Portland, OR
Contact: Dr. Wassana Yantasee, CEO, [email protected]; Dr. Worapol Ngamcherdtrakul, COO, [email protected]; Website: www.pdxpharm.com . Market Opportunity โข Global โฆSee details»
Pdx Pharmaceuticals, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Pdx Pharmaceuticals, Inc. of Portland, OR. Get the latest business insights from Dun & Bradstreet.See details»
PDX PHARMACEUTICALS, LLC - VentureRadar
Develops next-generation combination immunotherapies for cancer using advanced nanotechnology, focusing on targeted delivery of siRNA, drugs, vaccines, and immunotherapies.See details»
PDX Pharmaceuticals - Org Chart, Teams, Culture & Jobs - The Org
Pdx Pharmaceuticals is a biopharmaceutical company. They provide common biological pathways to achieve synergistic clinical benefit. Their therapeutic candidates bridge the innate and โฆSee details»
PDX Pharmaceuticals, Inc. - CMOCRO
PDX Pharmaceuticals, specialize in the development of chemically modified nanomaterials into drugs. These materials hold great promise for improving healthcare outcomes and greatly โฆSee details»
Team | PDX Pharmaceuticals
COLLABORATORS AND SCIENTIFIC ADVISORS. PDX Pharmaceuticals has been in long-term collaboration with the OHSUโs Biomedical Engineering, the OHSU Center for Spatial Systems โฆSee details»
PDX Pharmaceuticals, Inc. (PDX Pharmaceuticals, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ โฆ
May 7, 2025 Abstract Metastatic non-small cell lung cancer (NSCLC) is a highly lethal cancer with limited effective treatment options. Although immune checkpoint inhibitors show some โฆSee details»
Contact us | PDX Pharmaceuticals
Center for Health & Healing Building 1 3303 S Bond Avenue, CH13B, 13TH Floor Portland, OR 97239 Tel: (503) 418-0483 DirectionsSee details»
About PDX | PDX Pharmaceuticals
Click here to view the one-pager about PDX Pharmaceuticals PDX Pharmaceuticals. Founded in 2010 as a start-up from the Biomedical Engineering Department (BME) at Oregon Health and โฆSee details»
Recent news & Events | PDX Pharmaceuticals
PDX Pharma was awarded a new grant from NCI 9/23/2024. We are pleased to share that PDX Pharmaceuticals has received a $250,000 SBIR Commercialization Readiness Program โฆSee details»
PDX Pharmaceuticals - Facebook
Sep 13, 2024 *Highlights from BIO International 2024* PDX Pharmaceuticals had a fantastic week at BIO International earlier this month in San Diego! Our Head of Research & COO, Dr. โฆSee details»
Worapol (Boom) Ngamcherdtrakul - Head of Research & COO
Head of Research & COO at PDX Pharmaceuticals · Experience: PDX Pharmaceuticals · Education: Oregon Health and Science University · Location: Portland · 343 connections on โฆSee details»
OxyContin maker Purdue Pharma asks court to clear way for $7
11 hours ago The deal would be among the largest in a wave of opioid settlements. It calls for members of the Sackler family who own the company to give up ownership and to contribute โฆSee details»
Technology | PDX Pharmaceuticals
ARAC-02 development achieved the perfect score during SBIR grant review, and won $2.3M award from the NCI in 2021. Data on its first-gen ARAC was published in Nature โฆSee details»